Dalbavancin: novel candidate for COVID-19 treatment.
Cell Res
; 31(3): 243-244, 2021 03.
Article
in English
| MEDLINE | ID: covidwho-1039636
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Teicoplanin
/
COVID-19 Drug Treatment
/
Anti-Bacterial Agents
Type of study:
Prognostic study
Topics:
Traditional medicine
Limits:
Animals
/
Humans
Language:
English
Journal:
Cell Res
Year:
2021
Document Type:
Article
Affiliation country:
S41422-020-00459-5
Similar
MEDLINE
...
LILACS
LIS